T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Not Recruiting

Trial ID: NCT01078337

Age - N/A-18 Years Condition - Acute Lymphoid leukemia (ALL), Pediatric Cancer Gender - ALL Accepting Healthy Volunteers - No

Purpose

To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).

Official Title

T-cell MRD Evaluation Using Flow Cytometric Analysis

Stanford Investigator(s)

Gary Dahl

Eligibility

Inclusion Criteria:

* Children with newly diagnosed T-cell ALL

View More
View Less

Intervention(s):

procedure: Bone marrow aspiration

procedure: peripheral blood sampling

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Nadeem Mukhtar
6504978815

New Trial Alerts

©2024 Stanford Medicine